Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Anixa Biosciences Inc ANIX

Healthcare Biotechnology
Anixa Biosciences, Inc. is a biotechnology company developing vaccines and therapies that are focused on critical unmet needs in oncology. Its segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Other. Its vaccine programs include the development of a preventative vaccine against triple negative breast cancer (TNBC), the most lethal form of breast cancer, as well... see more

Recent & Breaking News (NDAQ:ANIX)

Anixa Biosciences to Present at Biotech Showcase 2020

PR Newswire December 23, 2019

Anixa Biosciences Announces Commercial Launch of Cchek(TM) Prostate Cancer Confirmatory Test

PR Newswire December 16, 2019

Anixa Biosciences to Host Conference Call to Discuss Plans for 2020

PR Newswire December 13, 2019

Anixa Biosciences Provides Update on CAR-T Program

PR Newswire December 13, 2019

Anixa Biosciences Announces Presentation at the 2019 San Antonio Breast Cancer Symposium

PR Newswire December 2, 2019

Anixa Biosciences Announces Genesis Research to Join Cchek(TM) Prostate Cancer Study

PR Newswire November 26, 2019

Anixa Biosciences Announces Collaboration with Urology Centers of Alabama on Cchek(TM) Prostate Cancer Study

PR Newswire November 22, 2019

Anixa Biosciences Announces Collaboration with Idaho Urologic Institute on Cchek(TM) Prostate Cancer Study

PR Newswire November 20, 2019

Anixa Biosciences Announces Presentation at Cell Symposia: Hallmarks of Cancer

PR Newswire November 7, 2019

Anixa Biosciences Announces Patent Issued for its Breast Cancer Vaccine

PR Newswire November 5, 2019

Anixa Biosciences Names Novartis Executive Dr. Emanuele Ostuni to Scientific Advisory Board

PR Newswire October 28, 2019

Anixa Biosciences Announces Collaboration with Urology San Antonio on Cchek(TM) Prostate Cancer Study

PR Newswire October 25, 2019

Anixa Biosciences Announces Abstract Accepted for Presentation at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2019)

PR Newswire October 22, 2019

Anixa Biosciences Appoints Dr. Thomas Schlumpberger as Executive Vice President of Diagnostics to Head Liquid Biopsy Development and Commercialization Efforts

PR Newswire October 15, 2019

Anixa Biosciences Names Cancer Vaccine Pioneer Dr. Ian H. Frazer to Scientific Advisory Board

PR Newswire October 10, 2019

Anixa Biosciences Announces University of Maryland School of Medicine to Join Cchek(TM) Prostate Cancer Study

PR Newswire September 23, 2019

Anixa Biosciences Commences Collaboration with Potomac Urology Center on Cchek(TM) Prostate Cancer Study

PR Newswire September 19, 2019

Anixa Biosciences Congratulates Scientific Advisory Board Member Dr. H. Michael Shepard as a 2019 Lasker Award Honoree

PR Newswire September 16, 2019

Anixa Biosciences to Present at Two Upcoming Investor Conferences

PR Newswire August 26, 2019

Anixa Biosciences Announces VA North Texas Health Care System to Join Cchek(TM) Prostate Cancer Study

PR Newswire July 29, 2019